[EN] PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS<br/>[FR] MÉTABOLITES PROTÉGÉS À BASE D'ACIDE CARBOXYLIQUE POUR LE TRAITEMENT DES MALADIES LIÉES À DES DYSFONCTIONS MITOCHONDRIALES
申请人:NEUROVIVE PHARMACEUTICAL AB
公开号:WO2017060400A1
公开(公告)日:2017-04-13
The present invention provides novel cell-permeable carboxylic acid- based metabolites and cell permeable precursors thereof aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high- energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane. The provision of the novel cell permeable carboxylic acid-based metabolites is envisaged to allow passage over the cellular membrane and thus the cell permeable carboxylic acid-based metabolites can be used to enhance mitochondrial ATP-output.